Labshake search
Citations for R&D Systems :
1 - 50 of 1817 citations for Wnt3a Human HEK293 since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2020Quote: ... human WNT3a (R&D Systems) and/or PI-88 (gift of Medigen Biotechnology Corp ...
-
bioRxiv - Physiology 2022Quote: ... Recombinant human WNT3A (R&D Systems) and recombinant human Norrin (R&D Systems ...
-
bioRxiv - Cell Biology 2023Quote: ... 100 ng/ml human Wnt3a (R&D Systems) was added ...
-
bioRxiv - Cell Biology 2022Quote: ... recombinant human WNT3A (0.01 μg/ml, R&D Systems) or recombinant human WNT5A (0.01 μg/ml ...
-
bioRxiv - Cell Biology 2023Quote: ... 100 ng/mL recombinant human Wnt3A (R&D Systems), 500 nM A83-01 (R&D Systems) ...
-
bioRxiv - Cancer Biology 2020Quote: ... 200 ng of recombinant human Wnt3A (R&D Systems, MN; 5036WN010) were conjugated to 12 µg of PlnDmI in 20 mM HEPES ...
-
bioRxiv - Cell Biology 2022Quote: ... Some cells were treated 0.01µg/ml recombinant human WNT3A (R&D Systems) as positive control ...
-
bioRxiv - Cancer Biology 2021Quote: ... Recombinant human Wnt3A (5036-WN-010) was purchased from R&D Systems. For knockdown experiments ...
-
bioRxiv - Cell Biology 2023Quote: ... 50 ng/ml recombinant human Wnt3a (R&D Systems; day 1 and 2), 1 mM L-Glutamine (L-Glu ...
-
bioRxiv - Neuroscience 2021Quote: ... Wnt3a (R&D Systems) was used at 20 ng/mL ...
-
bioRxiv - Neuroscience 2021Quote: WNT3a (R&D Systems) and SR11302 (TOCRIS ...
-
bioRxiv - Molecular Biology 2022Quote: ... Recombinant human WNT3A and R-spondin 3 were from R&D Systems (Minneapolis, USA).
-
bioRxiv - Cancer Biology 2023Quote: ... 200ng/mL recombinant Human Wnt3a (R&D System, Cat. No. 5036-WN-010/CF) or Wnt5a (R&D System ...
-
bioRxiv - Cancer Biology 2020Quote: ... CMK lines were treated with 200 ng/ml of recombinant human WNT3A (R&D systems) for 4 hours ...
-
bioRxiv - Cell Biology 2020Quote: ... with 25 ng/ml recombinant human WNT3A (R&D Systems, cat. no. 5036-WN-010) and 100 ng/ml Activin A (Humanzyme ...
-
bioRxiv - Developmental Biology 2020Quote: ... while WNT3A (R&D Systems) was used at a concentration of 50ng/ml ...
-
bioRxiv - Cell Biology 2023Quote: ... HEK293-derived human Shh (R&D Systems, 8908-SH) served as a bioactivity control and to quantify Bosc23-expressed ...
-
bioRxiv - Cell Biology 2024Quote: ... Cells were treated with either BSA or human recombinant WNT3a (5036-WN-010, R&D Systems) 24 hours later ...
-
bioRxiv - Bioengineering 2019Quote: ... or and Wnt3a (R&D Systems). All animal experiments were approved by the North Stockholm regional committee for animal research and ethics ...
-
bioRxiv - Genomics 2022Quote: ... WNT3a (5036-WN, R&D System). After 3 weeks ...
-
bioRxiv - Developmental Biology 2023Quote: ... Wnt3a protein from R&D Systems/Biotechne (5036- WN-010 ...
-
bioRxiv - Cancer Biology 2021Quote: ... Wnt3a ligand (R&D systems 5036-WN) at 100ng/ml was added to the culture.
-
bioRxiv - Developmental Biology 2021Quote: ... 100 ng/ml WNT3a (R&D Systems), 6 μM CHIR99021 (EMD Millipore ...
-
bioRxiv - Cell Biology 2020Quote: ... recombinant Wnt3a (10ng/ml; R&D Systems) for stimulation and XAV939 (10μM ...
-
bioRxiv - Cancer Biology 2021Quote: ... Wnt3a ligand (R&D systems 5036-WN) at 100ng/ml was added to the culture ...
-
bioRxiv - Developmental Biology 2022Quote: ... Wnt3a (100 ng/ml, R&D systems, cells were incubated in serum-free medium for 20 hours ...
-
bioRxiv - Neuroscience 2023Quote: ... 10 ng/ml Wnt3a (R&D Systems), and 1 μg/ml laminin for 2 weeks ...
-
bioRxiv - Developmental Biology 2023Quote: ... 50 ng/ml WNT3a (R&D Systems)] into low attachment plates ...
-
bioRxiv - Cell Biology 2021Quote: ... 25 ng/mL mouse Wnt3a (R&D Systems).
-
bioRxiv - Cell Biology 2022Quote: ... Cells were treated with Wnt3a (R&D Systems), Noggin (Miltenyi Biotec) ...
-
bioRxiv - Biochemistry 2023Quote: ... and Wnt3a were purchased from R&D Systems. A83-01 (catalog 100-1041 ...
-
bioRxiv - Cell Biology 2019Quote: ... Recombinant human WNT3A (#5036-WN-010) and WNT4 (#6076-WN-005) were obtained from R&D Systems (Minneapolis, MN, USA) and reconstituted per the manufacturer’s instructions.
-
bioRxiv - Developmental Biology 2022Quote: ... WNT3A (200 ng/ml; R&D systems, Minneapolis, MN), WNT5A (100 ng/ml ...
-
bioRxiv - Genetics 2019Quote: ... supplemented with Wnt3a (20 ng/ml; R&D Systems) and Activin A (100 ng/ml ...
-
bioRxiv - Genetics 2019Quote: ... supplemented with Wnt3a (20 ng/ml; R&D Systems) and Activin A (100 ng/ml ...
-
bioRxiv - Cell Biology 2021Quote: ... Wnt3a(150ng/ml)(1324-WNP-010, R&D Systems) and PBS/BSA(control ...
-
Pseudohypoxic HIF pathway activation dysregulates collagen structure-function in human lung fibrosisbioRxiv - Cell Biology 2021Quote: ... Wnt3a (R&D systems, 5036-WN-010, 100ng/mL), Wnt5a (R&D systems ...
-
bioRxiv - Neuroscience 2023Quote: ... member 3A (Wnt3A) (10 ng/mL, R&D Systems) and cyclopamine (1 μM ...
-
bioRxiv - Developmental Biology 2020Quote: ... 25 ng/mL Wnt3a (R&D systems 5036-WN-010), 5 ng/mL IGF1 (Sigma 13769-50UG) ...
-
bioRxiv - Cell Biology 2020Quote: ... WNT3a (90 ng/ml) (R&D systems, Cat.no. 5036-WN) for 2 or 24h.
-
bioRxiv - Cell Biology 2022Quote: ... A stock solution of recombinant mouse Wnt3A (R&D systems) was prepared at 40 μg/ml in 0.1% BSA/PBS and used between 10-100 ng/ml concentration in culture.
-
bioRxiv - Immunology 2021Quote: ... 10 ng/mL Wnt3a (R&D Systems, Cat# 5036-WN-010), 0.1 % Methylcelluose (R&D Systems ...
-
bioRxiv - Cell Biology 2022Quote: ... Wnt3a (100 ng/ml, R&D Systems, 1324-WN-002/CF) and AMD3100 (200 ng/ml ...
-
bioRxiv - Developmental Biology 2023Quote: Wnt3a was manufactured by R&D Systems (1324-WN-010/CF) and used at 200 ng/ml for 24 h induction ...
-
bioRxiv - Physiology 2024Quote: ... minus 10 nM prostaglandin E2 and 2.5 μM Thiazovinin and with added human recombinant Wnt3A 50 ng/mL (R&D Systems, #5036-WN-010/CF), R-Spondin-1 250 ng/mL (Peprotech ...
-
bioRxiv - Cell Biology 2021Quote: ... 100 ng/ml Act A + 50 ng/ml Wnt3A (R&D Systems), (iii ...
-
bioRxiv - Cell Biology 2021Quote: ... cells were treated with 100 ng/ml recombinant WNT3A (R&D Systems).
-
bioRxiv - Cell Biology 2022Quote: ... and Wnt3a (100 ng/ml, R&D Systems, 1324-WN-002/CF). Treated cells were incubated for 48 hours and Axin2 gene expression was evaluated using the protocol described above ...
-
bioRxiv - Genetics 2019Quote: ... 100 ng /ml activin A and 50 ng /ml WNT3a (R&D Systems). Day 2 ...
-
bioRxiv - Cell Biology 2022Quote: ... 25 ng/mL Wnt3a (R&D Systems, 5036-WN, only on day 0).